GlaxoSmithKline's achievements in drug research and development
-
Last Update: 2014-03-10
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
Source: Biovalley 2014-3-10 according to statistics, GlaxoSmithKline, a pharmaceutical giant, had 20 drugs or vaccines approved by FDA from 2008 to 2013 This figure also makes GlaxoSmithKline in the biomedical research and development market Novartis, Johnson & Johnson and Bayer have 13, 9 and 7 drugs approved, respectively This result is attributed to the effective R & D reorganization of GSK However, although GSK's pharmaceutical research and development achievements are fruitful, GSK's new drug return is not the highest It is estimated that the total revenue of these new drugs will reach 11.7 billion US dollars by 2018, while that of Johnson & Johnson and Pfizer will reach 13.1 billion US dollars and 12 billion US dollars in the same period At the bottom of the list are Lilly and AstraZeneca, while Sanofi has six drugs approved by the FDA in the same period.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
